FDA grants orphan drug status for Treanda for CLL
Friday August 31, 2007
On August 29, 2007, the U.S. Food and Drug Administration (FDA) granted orphan drug designation to Treanda (bendamustine HCl, developed by Cephalon, Inc.), for the treatment of chronic lymphocytic leukemia ... Read More
September is National Sickle Cell Disease Awareness Month in U.S.
Thursday August 30, 2007
September 2007 is National Sickle Cell Disease Awareness Month in the United States. The Sickle Cell Disease Association of America states that it wants the public to reflect on the ... Read More
Takayasu Arteritis
Sunday August 26, 2007
Takayasu arteritis is a serious chronic inflammatory disease of the large arteries, usually affecting the aorta and its large branches. Although the cause of the disease is unknown, studies suggest ... Read More
Study finds obesity a risk factor for multiple myeloma
Friday August 24, 2007
A study published in the July 2007 issue of Cancer Epidemiology Biomarkers & Prevention found that obesity, as defined by a body mass index (BMI) of 30 or greater, was ... Read More
Improving sleep helps mice with Huntington disease
Tuesday August 21, 2007
Researchers in Cambridge, England, studied the sleeping and waking cycles of mice with the genetic mutation for Huntington disease (HD), an inherited neurological disorder. The researchers found that these mice ... Read More
Newborn Screening for Genetic and Metabolic Disorders
Sunday August 19, 2007
Newborn babies around the world are tested shortly after birth for genetic or metabolic disorders such as sickle cell disease and phenylketonuria. Early detection, diagnosis, and treatment of these disorders ... Read More
FDA grants orphan status for three drugs
Thursday August 16, 2007
5(S)-(2'-hydroxyethoxy)-20(S)-camptothecin
On June 15, 2007, the U.S. Food and Drug Administration (FDA) granted orphan drug status to the drug 5(S)-(2'-hydroxyethoxy)-20(S)-camptothecin (made by ClinTec International, Ltd) for the treatment of osteosarcoma, a ... Read More
Gene therapy improves immune function in older children with SCID
Tuesday August 14, 2007
Researchers at the National Institute of Allergy and Infectious Diseases and their colleagues studied three youth (ages 10, 11 and 14 years) who had X-linked severe combined immunodeficiency (SCID), in ... Read More
Fucosidosis
Sunday August 12, 2007
In this disorder, an enzyme (alpha-fucosidase) is missing in the body. Without it, the body can't finish breaking down certain sugar, fat, and protein molecules into their useful parts. The ... Read More
FACES to FACES 2007 Encephalitis Conference August 17-19
Wednesday August 8, 2007
The FACES to FACES 2007 Encephalitis Conference will be held August 17 to 19 in Nashville, Tennessee. FACES (Friends And Caregivers Encephalitis Survivors) welcomes anyone who has been touched by ... Read More
August is Spinal Muscular Atrophy Awareness Month in U.S.
Tuesday August 7, 2007
Spinal muscular atrophy is a group of inherited disorders that destroys the nerves controlling voluntary muscle movement. There is no cure, but organizations such as Families of Spinal Muscular Atrophy ... Read More
Einsenmenger Syndrome
Sunday August 5, 2007
Eisenmenger syndrome develops in individuals with significant heart defects. In Eisenmenger syndrome, blood pressure increases in the lungs (called pulmonary hypertension). Usually, the syndrome develops while individuals with heart defects ... Read More
Team identifies gene variant associated with sporadic ALS
Friday August 3, 2007
Amyotrophic laterals sclerosis (ALS, or Lou Gehrig's disease) is either inherited (about 5 percent of cases) or occurs in a person with no family history of the disease (sporadic form). ... Read More
U.S. FDA OOPD clinical trials grants available
Thursday August 2, 2007
The U.S. Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) is pleased to announce the availability of funds for fiscal year (FY) 2009 and FY 2010 grant ... Read More
